rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.
21228335
2011
rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
20921465
2010
rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
20921462
2010
rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.
19114683
2009
rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
19679400
2009
rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
18316791
2008
rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.
16618717
2006
rs121913527
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
G
0.700
CausalMutation
CLINVAR
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
16361624
2005